ARCHIVES

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

House Passes Bill On New Cigarette Labels

September 14, 1984

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

White House Seek Elimination Of NCI’s Bypass Budget Authority In Legislation Renewing Cancer Act

April 9, 1982

In Brief: Kovac, Bunn Lead AACI; Hollings Researcher Wins Immunology Award; Turrisi Moves To SC

September 16, 1994

Sandra Swain at ASCO 2013: Let’s Focus on Three Goals

June 7, 2013